Condition 101 About Apolipoprotein C2 Deficiency

Condition 101 content is not available at this time, but we are continually updating the site. Please check back.

However, there may be experts who have treated this or similar conditions in our Find a Doctor section and research may be available in our Latest Advances section.

Top Global Doctors For Apolipoprotein C2 Deficiency

View All Doctors

Latest Advances On Apolipoprotein C2 Deficiency

  • Condition: Familial Chylomicronemia Syndrome due to Heterozygous Deletion of Chromosome 8
  • Journal: Medicine
  • Treatment Used: Volanesorsen
  • Number of Patients: 1
  • Published —
This case report describes a 52-year-old woman with familial chylomicronemia syndrome due to a heterozygous deletion of the chromosome 8 treated with volanesorsen.
  • Journal: Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists
  • Published —
THE PREVALENCE OF PROBABLE FAMILIAL CHYLOMICRONEMIA SYNDROME IN A SOUTHERN CALIFORNIA POPULATION.
View All Latest Advances

Clinical Trials For Apolipoprotein C2 Deficiency

Clinical Trial
  • Status: Recruiting
  • Phase: Phase 2
  • Intervention Type: Other, Drug
  • Participants: 120
  • Start Date: July 12, 2021
A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Evinacumab in Patients With Severe Hypertriglyceridemia for the Prevention of Recurrent Acute Pancreatitis
Clinical Trial
  • Status: Active, not recruiting
  • Intervention Type: Other
  • Participants: 16
  • Start Date: June 27, 2014
Glybera Registry, Long-term Safety and Efficacy Follow-up in Lipoprotein Lipase Deficient (LPLD) Patients Treated With Alipogene Tiparvovec (GLYBERA®)
View All Clinical Trials